Brief: Hybrigenics to present new in vitro data on inecalcitol in chronic myeloid leukemia

Aton SA

19/11/2015 07:17

Nov 19 (Reuters) - Hybrigenics SA  ALHYG.PA : 
    * To present new in vitro data on Inecalcitol in chronic 
myeloid leukemia (CML) at ASH conference in the United States 
    * Inecalcitol inhibits the proliferation in vitro of stem 
cells of patients with CML in synergy with Imatinib, Nilotinib 
or Dasatinib 
    * Inecalcitol alone resulted in the in vitro inhibition of 
the growth of CML stem cell cultures isolated from 15 out of 18 
patients 
    * Macrophage genes specifically induced in vitro by 
Inecalcitol were identified as potential biomarkers predictive 
of the clinical response to Inecalcitol 
 
     
Source text: http://bit.ly/1SGnGTo 
Further company coverage:  ALHYG.PA  
 
 (Gdynia Newsroom:) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))